Moderna (MRNA)
NASDAQHealth CareBiotechnologySnapshot 2026-07-07
$79.77-2.48%
Close 2026-07-07 · 1-day change
Reading MRNA? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track MRNA free→NASDAQHealth CareBiotechnologySnapshot 2026-07-07
Reading MRNA? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track MRNA free→QuarterlyIQ Insights · MRNA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | 2,225.0 | 1,944.0 | 3,236.0 | 6,848.0 | 803.0 | 803.0 | 803.4 | 60.2 | 108.4 |
| Total Revenues | — | — | — | — | 803.0 | 803.0 | 803.4 | 60.2 | 108.4 |
| Cost of Revenues | 1,733.0 | 868.0 | 1,464.0 | 4,693.0 | 8.0 | 8.0 | 7.9 | — | — |
| Operating Expenses & Income | |||||||||
| R&D Expenses | 2,925.0 | 3,132.0 | 4,543.0 | 4,845.0 | 1,370.0 | 1,370.0 | 1,370.3 | 496.3 | 274.7 |
| Operating Income | (3,412.0) | (3,074.0) | (3,945.0) | (4,239.0) | (763.0) | (763.0) | (763.1) | (545.7) | (223.8) |
| Earnings from Continuing Operations | |||||||||
| Interest & Investment Income | 296.0 | 314.0 | 425.0 | 421.0 | 25.0 | 25.0 | 24.7 | 38.5 | 11.3 |
| Asset Writedown | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.6 | — | — |
| EBT, Incl. Unusual Items | (3,138.0) | (2,768.0) | (3,607.0) | (3,942.0) | (744.0) | (744.0) | (744.5) | (514.7) | (215.2) |
| Income Tax Expense | 56.0 | 54.0 | (46.0) | 772.0 | 3.0 | 3.0 | 2.6 | (0.7) | 1.0 |
| Net Income | |||||||||
| Net Income | (3,194.0) | (2,822.0) | (3,561.0) | (4,714.0) | (747.0) | (747.0) | (747.1) | (514.0) | (216.2) |
| Per Share | |||||||||
| Basic EPS | (8.09) | (7.26) | (9.28) | (12.33) | (1.96) | (1.96) | — | — | — |
| Diluted EPS | (8.09) | (7.26) | (9.28) | (12.33) | (1.96) | (1.96) | — | — | — |
| Revenue per Share | 5.63 | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 395.0 | 389.0 | 384.0 | 382.0 | 381.0 | 381.0 | — | — | — |
| Diluted Weighted Avg Shares | 395.0 | 389.0 | 384.0 | 382.0 | 381.0 | 381.0 | — | — | — |
| Supplemental | |||||||||
| EBITDA | — | (2,863.0) | (3,760.0) | (3,622.0) | (732.0) | (732.0) | (731.9) | (514.7) | (208.7) |
| EBIT | (3,412.0) | (3,074.0) | (3,945.0) | (4,239.0) | (763.0) | (763.0) | (763.1) | (545.7) | (223.8) |
| Effective Tax Rate | -1.8% | -2.0% | 1.3% | -19.6% | -0.4% | -0.4% | -0.3% | 0.1% | -0.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.